RGT fundamentals
An in-depth look to ARGENT BIOPHARMA LIMITED operating, investing, and financing activities
RGT free cash flow for H1 24 is -7.92 M AUD. For 2023, RGT free cash flow was -12.18 M AUD and operating cash flow was -11.99 M AUD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
TTM